Treatment of Squamous Cell Carcinoma of the Oral Cavity, Oropharynx and Hypopharynx: An Analysis of 174 Patients in South Western Finland

Acta Oncologica

Volumn 42, Issue 7, 2003, Pages 756-762

  Luukkaa, Marjaana ^a   Minn, Heikki ^a   Aitasalo, Kalle ^a   Kronqvist, Pauliina ^a   Kulmala, Jarmo ^a   Pyrhönen, Seppo ^a   Grénman, Reidar ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; CYTOLOGY; DRUG DOSAGE; ONCOLOGY; RADIOTHERAPY; SURGERY;

MORBIDITY; SQUAMOUS CELL CARCINOMA (SCC);

TUMORS;

ADULT; AGED; ARTICLE; BONE NECROSIS; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DENTIST; DOCTOR PATIENT RELATION; FEASIBILITY STUDY; FEMALE; HEAD CANCER; HUMAN; HUMAN TISSUE; HYPOPHARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MOUTH CARCINOMA; MUCOSA INFLAMMATION; NECK CANCER; OROPHARYNX CARCINOMA; PATIENT REFERRAL; POSTOPERATIVE COMPLICATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; SQUAMOUS CELL CARCINOMA; SURGEON; SURVIVAL RATE; TONGUE CARCINOMA; TREATMENT OUTCOME; TUMOR LOCALIZATION; UNIVERSITY HOSPITAL;

AGED; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FINLAND; HUMANS; HYPOPHARYNGEAL NEOPLASMS; LYMPHATIC IRRADIATION; MOUTH NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; OROPHARYNGEAL NEOPLASMS; RADIOTHERAPY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0345448994     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841860310010907     Document Type: Article

References (32)

1. Teppo H, Koivunen P, Sipilä S, et al. Decreasing incidence and improved survival of laryngeal cancer in Finland. Acta Oncol 2001; 40: 791-5.
2. Raitiola HS, Pukander JS. Changing trends in the incidence of laryngeal cancer. Acta Oncol 1997; 36: 33-6.
3. Raitiola H, Pukander J. Symptoms of laryngeal carcinoma and their prognostic significance. Acta Oncol 2000; 39: 213-6.
4. Virtaniemi JA, Hirvikoski PP, Kumpulainen EJ, et al. Is the subsite distribution of laryngeal cancer related to smoking habits? Acta Oncol 2000; 39: 77-9.
5. Finnish Cancer Registry. Annual Reports. Cancer Incidence in Finland 1968-1997. Helsinki: Finnish Cancer Registry, Helsinki, 1971-2000.
6. Dickman PW, Hakulinen T, Luostarinen T, et al. Survival of cancer patients in Finland 1955-1994. Acta Oncol 1999; 38(Suppl 49): 1-103.
7. Parsons JT, Mendenhall WM, Stringer SP, et al. Squamous cell carcinoma of the oropharynx - surgery, radiation, or both. Cancer 2002; 11: 2967-80.
8. Bhattacharyya N. The effects of more conservative neck dissections and radiotherapy on nodal yields from the neck. Arch Otolaryngol Head Neck Surg 1998; 124: 412-6.
9. Bengtson GP, Schusterman MA, Baldwin BJ, et al. Influence of prior radiotherapy on the development of postoperative complications and success of free tissue transfers in head and neck cancer reconstruction. Am J Surgery 1993; 166: 326-30.
10. Cummings CW, Fredricsson JM, Harker LE, Krause CJ, Richardson MA, Schuller DE. Otolaryngology - head and neck surgery, 3d ed. Missouri: Mosby Year Book, St Louis; 1998.
11. Wratten CR, Puolsen MG, Williamson S, et al. Effect of surgery on normal tissue toxicity in patients treated with accelerated radiotherapy. Acta Oncol 2002; 41: 56-62.
12. Sobin LH, Wittekind Ch. TNM Atlas. Illustrated guide to the TNM/pTNM classification of malignant tumours. 3rd ed, 2nd revision. New York, Berlin, Heidelberg: Springer-Verlag; 1992.
13. Zubrod GG. Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphamide. J Chron Dis 1960; 11: 7-33.
14. Histological typing of tumours of the upper respiratory tract and ear. International histological classification of tumours. World Health Organization. Berlin: Springer Verlag; 1991.
15. Luukkaa M, Aitasalo K, Pulkkinen J, et al. Neodymium YAG contact laser in the treatment of cancer in mobile tongue. Acta Otolaryngol 2002; 122: 318-22.
16. Kramer D, Durham JS, Jackson S, et al. Management of the neck in NO squamous cell carcinoma of the oral cavity. J Otolaryngol 2001; 30: 283-8.
17. Haddadin KJ, Soutar DS, Oliver RJ, Webster MH, Robertson AG, MacDonald DG. Improved survival for patients with clinically T1/T2, N0 tongue tumors undergoing a prophylactic neck dissection. Head Neck 1999; 21: 517-25.
18. Dias FL, Klingerman J, Matos de Sa G, et al. Elective neck dissection versus observation in stage I squamous cell carcinomas of the tongue and floor of the mouth. Otolaryngol Head Neck Surg 2001; 125: 23-9.
19. Wang CC. Radiation therapy for head and neck neoplasms, 3rd ed. New York: Wiley-Liss; 1997. p. 124-36.
20. Robbins KT, Medina JE, Wolfe GT, Levine PA, Sessions RB, Pruet CW. Standardizing neck dissection terminology, official report of the Academy's Committee for Head and Neck Surgery and Oncology. Arch Otolaryngol Head Neck Surg 1991; 117: 601-5.
21. Verdecchia A, Capocaccia M, Santaquilani M, Hakulinen T. Methods of survival data analysis and presentation issues. In: Berrino F, Capocaccia R, Esteve J, et al., eds. Survival of cancer patients in Europe: the EUROCARE-2 Study. Lyon: IARC Scientific Publications 1999; 151: 41-5.
22. Annertz K, Anderson H, Biorklund A, et al. Incidence and survival of squamous cell carcinoma of the tongue in Scandinavia, with special reference to young adults. Int J Cancer 2002; 101: 95-9.
23. Stuschke M, Thames HD. Hyperfractionated radiotherapy of human tumors: overview of the randomized clinical trials. Int J Radiation Oncol Biol Phys 1997; 37: 259-67.
24. Lundahn RE, Foote RL, Bonner JA, et al. Combined neck dissection and postoperative radiation therapy in the management of the high-risk neck: matched-pair analysis. Int J Radiat Oncol Biol Phys 1998; 40: 529-34.
25. Nathanson A, Ågren K, Biörklund A, et al. Evaluation of some prognostic factors in small squamous cell carcinoma of the mobile tongue: a multicenter study in Sweden. Head Neck 1989; 11: 387-92.
26. Vermund H, Boysen M, Evensen JF, et al. Recurrence after different primary treatment for cancer of the supraglottic larynx. Acta Oncol 1998; 37: 167-73.
27. Jakobsen J, Hansen O, Jorgensen KE, et al. Lymph node metastases from laryngeal and pharyngeal carcinomas - calculation of burden of metastasis and its impact on prognosis. Acta Oncol 1998; 37: 489-93.
28. Leon X, Quer M, Diez S, et al. Second neoplasm in patients with head and neck cancer. Head Neck 1999; 21: 204-10.
29. Glanzmann C, Grätz KW Radionecrosis of the mandibula: a retrospective analysis of the incidence and risk factors. Radiother Oncol 1995; 36: 94-100.
30. Kramer S, Gelber RD, Snow JB, et al. Combined radiation therapy and surgery in the management of advanced head and neck cancer: final report of study 73-03 of the Radiation Therapy Oncology Group. Head Neck Surg 1987; 10: 19-30.
31. Ang KK, Trotti A, Brown BW, et al. randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001; 51: 571-8.
32. Perez C A, Brady L W. Principles and practice of radiation oncology, 3rd ed. Philadelphia, New York: Lippincott-Raven; 1998. p. 981-1068.